Search - tctmd.com

Displaying 521 - 540 of 1894

Sort: Relevancy | Date

News Daily News

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Michael O'Riordan

January 05, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for December 2022

Shelley Wood

January 03, 2023

News Daily News

Top Endovascular News of 2022

L.A. McKeown

January 03, 2023

News Daily News

Top Policy and Practice News for Cardiologists in 2022

Caitlin E. Cox

January 02, 2023

News Opinion Editor's Corner

The Biggest News of 2022: TCTMD’s Top 10

Shelley Wood

December 30, 2022

News Opinion CV Team Dispatch

December 2022 News Roundup

L.A. McKeown

December 28, 2022

News Daily News

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

Michael O'Riordan

December 22, 2022

News Daily News

It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies

Todd Neale

December 21, 2022

News Daily News

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

L.A. McKeown

December 20, 2022

News Daily News

Reduction in BP Drives Treatment Preference for Hypertensive Patients

Michael O'Riordan

December 20, 2022

News Daily News

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

L.A. McKeown

December 16, 2022

News Daily News

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

Todd Neale

December 16, 2022

News Daily News

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Michael O'Riordan

December 14, 2022

News Daily News

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

L.A. McKeown

December 12, 2022

News Daily News

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Yael L. Maxwell

December 12, 2022

News Daily News

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Todd Neale

December 09, 2022

News Daily News

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Michael O'Riordan

December 08, 2022

News Daily News

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Michael O'Riordan

December 07, 2022

News Daily News

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

Yael L. Maxwell

December 05, 2022

News Features

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

L.A. McKeown

December 02, 2022

Advertisement

Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

TCTMD’s Top 10 Most Popular Stories for December 2022

Top Endovascular News of 2022

Top Policy and Practice News for Cardiologists in 2022

The Biggest News of 2022: TCTMD’s Top 10

December 2022 News Roundup

Anatomic Disease After PCI Linked With Worse Outcomes: VA CART

It’s Time to Revamp How Clinical Trials Are Done, Say Cardiology Societies

Rare and Highly Variable, Cath Lab Cardiac Arrests Need More Study, Guidance

Reduction in BP Drives Treatment Preference for Hypertensive Patients

OSCAR Supports Rivaroxaban for Secondary VTE Prevention in Cancer

ACS Care in Older Patients Entails Unique Risks, Shifting Goals, Says AHA

FDA Advisors Recommend Against Approval of Omecamtiv Mecarbil

Global Cardio-Oncology Viewpoints ‘Contextualize’ ESC Guidelines

Inequities in Mitral, Tricuspid Trials Have Implications Across CV Research

Query Use of Nontraditional Therapies for HF at Every Visit: AHA Statement

Analysis Cements Benefits of SGLT2 Inhibitors in HF, but Diabetes Matters for Deaths

Large Review Plumbs Possibilities, Pointlessness of Antioxidant Supplements

Improving AED Use for OHCAs With an App? Neutral Study Shows It’s Complicated

Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content